Viatris Inc (VTRS) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
Total Cash From Operating Activities Chart for Viatris Inc
Viatris Inc (VTRS) operating cash flow for FY2025 was USD 2.3B, a 0.6% change from FY2024. Viatris Inc's operating cash flow grew from USD 51.2M in 1985 to USD 2.3B in 2025 (4423.2% over 40 years). Operating cash flow compound annual growth rate: 5-year CAGR of 13.5%, 10-year CAGR of 1.4%, 20-year CAGR of 9.0%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $18.64B
- Implied Share Price
- $16.23
- Enterprise Value
- $30.77B
- Revenue (TTM)
- $14.74B
- EBITDA
- $4.29B
- Profit Margin
- -2.79%
- Trailing P/E
- —
- Forward P/E
- 6.49
- Price/Book (MRQ)
- 1.31
- Price/Sales (TTM)
- 1.26
- EV/EBITDA
- 11.74
- EV/Revenue
- 2.09
- Dividend Yield
- 2.99%
- Book Value
- $12.59
- Free Cash Flow (FY2025)
- $1.94B
- Free Cash Flow Yield
- 10.39%
Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.